In general, EMRs at Investigator Sites are considered to be general patient medical records, and as such they are considered to be part of the practice of medicine which is not regulated by the FDA, nor are they presently required to be 21 CFR Part 11 compliant. The FDA expects, however, that their inspectors be provided the ability to review any information in the EMRs that is source data for the study in question.